1. Home
  2. CNTB vs OPXS Comparison

CNTB vs OPXS Comparison

Compare CNTB & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • OPXS
  • Stock Information
  • Founded
  • CNTB 2012
  • OPXS 1987
  • Country
  • CNTB United States
  • OPXS United States
  • Employees
  • CNTB N/A
  • OPXS N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • OPXS Electronic Components
  • Sector
  • CNTB Health Care
  • OPXS Technology
  • Exchange
  • CNTB Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • CNTB 55.2M
  • OPXS 45.6M
  • IPO Year
  • CNTB 2021
  • OPXS N/A
  • Fundamental
  • Price
  • CNTB $0.57
  • OPXS $5.75
  • Analyst Decision
  • CNTB Strong Buy
  • OPXS
  • Analyst Count
  • CNTB 1
  • OPXS 0
  • Target Price
  • CNTB $8.00
  • OPXS N/A
  • AVG Volume (30 Days)
  • CNTB 50.6K
  • OPXS 13.5K
  • Earning Date
  • CNTB 03-31-2025
  • OPXS 05-13-2025
  • Dividend Yield
  • CNTB N/A
  • OPXS N/A
  • EPS Growth
  • CNTB N/A
  • OPXS 42.37
  • EPS
  • CNTB N/A
  • OPXS 0.61
  • Revenue
  • CNTB $26,033,000.00
  • OPXS $35,225,000.00
  • Revenue This Year
  • CNTB $997.61
  • OPXS N/A
  • Revenue Next Year
  • CNTB N/A
  • OPXS N/A
  • P/E Ratio
  • CNTB N/A
  • OPXS $9.34
  • Revenue Growth
  • CNTB N/A
  • OPXS 23.22
  • 52 Week Low
  • CNTB $0.55
  • OPXS $5.39
  • 52 Week High
  • CNTB $2.66
  • OPXS $10.30
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 26.20
  • OPXS 46.62
  • Support Level
  • CNTB $0.80
  • OPXS $5.57
  • Resistance Level
  • CNTB $0.84
  • OPXS $6.18
  • Average True Range (ATR)
  • CNTB 0.08
  • OPXS 0.22
  • MACD
  • CNTB -0.02
  • OPXS 0.03
  • Stochastic Oscillator
  • CNTB 6.34
  • OPXS 45.63

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: